GlaxoSmithKline plc (GSK) is a global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. It has and operations in some 114 countries, with products sold in over 140 countries. The Company... more

Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs more than 5,000 people and operates in more than 150 countries worldwide. Its 2007... more

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer. The Company focuses on two systems for treating cancer: growth factor blockers and angiogenesis... more

CSL Limited is a biopharmaceutical company engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates in one segment, Human Health, which develops, manufactures and markets biopharmaceutical products to the human... more

YM BioSciences Inc. (YM BioSciences) is engaged in the licensing and commercialization of drug products and technologies from original research. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor... more

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that harness the immune system to fight cancer. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy... more

MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. As of December 31, 2007, the Company's lead investigational product candidate, the Technosphere... more

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes... more

Antigenics Inc. is a biotechnology company focused on developing technologies and product candidates to treat cancers and infectious diseases, primarily based on immunological approaches. The Company’s principal product candidate is Oncophage (vitespen), a patient-specific therapeutic... more

Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent development programs in the areas of infectious disease and... more

AVI BioPharma, Inc. (AVI) is a biopharmaceutical company developing therapeutic products principally based on third-generation NeuGene antisense technology. The Company’s principal products in development target life-threatening diseases, including cardiovascular, infectious, and genetic... more

Epimmune Inc. is a leader in using gene maps of cancer-associated proteins and infectious agents to design vaccines that induce cellular immunity. The company's technology platform is based on its pioneering work in deciphering the genetic code which regulates T-cell activation and... more

Advaxis, Inc., formerly Great Expectations, Inc., is a development-stage biotechnology company focused on developing cancer vaccines that utilize multiple mechanisms of immunity. The Company uses the Listeria system licensed from the University of Pennsylvania (Penn) to secrete a protein... more

Therion Biologics Corporation develops therapeutic vaccines that aim to extend and improve the lives of cancer patients. The company has two lead product candidates: PANVAC-VF, entering a Phase III clinical trial for pancreatic cancer; and PROSTVAC® -VF in a Phase II clinical trial for... more

AVAX Technologies, Inc. (AVAX) is a development stage biotechnology company specializing in the development and future commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. The Company's vaccine consists of autologous (the patient’s own)... more

MERIX Bioscience, Inc. is a venture capital-backed immunotherapy company with corporate headquarters in Durham, NC and a subsidiary company in Erlangen, Germany. The company is poised to assume leadership in the emerging area of dendritic cell research and development. On the basis of... more

Anosys develops innovative therapeutic vaccines for the treatment of cancer, infectious and autoimmune diseases. Anosys' healthcare products are based on a pioneering approach using exosomes, which represent a new paradigm in the understanding of intercellular communication. Exosomes from... more

Galenica was co-founded in 1996 by its principal officers: James S. Manuso, Ph.D., MBA, President and Chief Executive Officer; Dante J. Marciani, Ph.D., D.Sc., Chairman and Chief Scientific Officer, one of the world's most renowned vaccinologists; and David Vigor, MBA, Chief Financial... more

ODC Therapy Inc. is a cancer vaccine company focused on providing optimal dendritic cell therapies to individual patients. ODC has licensed a portfolio of intellectual property from Baylor Research Institute and Rockefeller University in the fields of immunotherapy and immunomonitoring.... more